"We are roughly 1 year away from proving whether Bisantrene is the world's first drug that synergises with chemotherapy to more effectively kill cancer while simultaneously protecting patients from its long-term toxicity."
Is there anything that could impact the timeline positively or negatively?
Cheers
RAC Price at posting:
$1.44 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)